skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods of treating parkinson's disease using viral vectors

Patent ·
OSTI ID:988144
 [1];  [2]
  1. Garrett Park, MD
  2. Alameda, CA
+ Show Author Affiliations

Methods of delivering viral vectors, particularly recombinant AAV virions, to the CNS are provided. Also provided are methods of treating Parkinson's Disease.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-05CH11231
Assignee:
Genzyme Corporation (Cambridge, MA); The Regents of the University of California (Oakland, CA)
Patent Number(s):
7,534,613
Application Number:
11/102,521
OSTI ID:
988144
Country of Publication:
United States
Language:
English

References (36)

Application of Gene Therapy for Parkinson's Disease: Nonhuman Primate Experience book January 1997
Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue—cannula sealing time journal February 1999
Increasing Volume of Distribution to the Brain with Interstiti; Infusion: Dose, Rather Than Convection, Might Be the Most Important Factor journal April 1996
Mechanism of MPTP toxicity: more answers, more questions journal January 1985
A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. journal January 1987
Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5 journal July 1977
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector journal June 1998
Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous System journal March 1997
l-Dopa and Dopamine-Producing Gene Cassettes for Gene Therapy Approaches to Parkinson's Disease journal March 1997
Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats journal December 1997
Long-term restoration of striatal l-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease journal August 1999
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain journal October 1994
Erratum journal January 1989
Adeno-associated virus vectors journal October 1992
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. journal May 1994
Viral Gene Delivery Selectively Restores Feeding and Prevents Lethality of Dopamine-Deficient Mice journal January 1999
Characterization of Intrastriatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer of Human Tyrosine Hydroxylase and Human GTP-Cyclohydrolase I in a Rat Model of Parkinson’s Disease journal June 1998
Effect of ischemic cerebral volume changes on behavior journal August 1997
Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene Therapy journal July 1994
Convection-Enhanced Delivery of Adeno-Associated Virus Type 2 (AAV2) into the Striatum and Transport of AAV2 Within Monkey Brain journal March 2006
Adeno-associated Virus Vector Containing the Herpes Simplex Virus Thymidine Kinase Gene Causes Complete Regression of Intracerebrally Implanted Human Gliomas in Mice, in Conjunction with Ganciclovir Administration journal January 1998
Adeno-associated virus vector-mediated transduction in the cat brain journal September 2003
Adeno-associated virus vectors can be efficiently produced without helper virus journal July 1998
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells book January 1992
Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's Disease journal March 1997
Gene Therapy in the United States: A Five-Year Status Report journal September 1996
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector journal January 1999
Transfer and Expression of Potentially Therapeutic Genes into the Mammalian Central Nervous System in Vivo Using Adeno-Associated Viral Vectors book January 1995
Prospects and problems of gene therapy: an update journal October 2001
Behavioral Recovery in 6-Hydroxydopamine-Lesioned Rats by Cotransduction of Striatum with Tyrosine Hydroxylase and Aromatic l -Amino Acid Decarboxylase Genes Using Two Separate Adeno-Associated Virus Vectors journal November 1998
Immunological Instability of Persistent Adenovirus Vectors in the Brain: Peripheral Exposure to Vector Leads to Renewed Inflammation, Reduced Gene Expression, and Demyelination journal May 1996
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. journal November 1993
A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes journal September 1998
Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system journal August 2005
Total synthesis of a human leukocyte interferon gene journal August 1981
Gene therapy - promises, problems and prospects journal September 1997

Similar Records

Related Subjects

60 APPLIED LIFE SCIENCES